506 related articles for article (PubMed ID: 16842311)
1. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model.
Tan C; Graudins A
Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311
[TBL] [Abstract][Full Text] [Related]
2. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
[TBL] [Abstract][Full Text] [Related]
3. Early presentation following overdose of modified-release paracetamol (Panadol Osteo) with biphasic and prolonged paracetamol absorption.
Graudins A; Pham HN; Salonikas C; Naidoo D; Chan B
N Z Med J; 2009 Aug; 122(1300):64-71. PubMed ID: 19701261
[TBL] [Abstract][Full Text] [Related]
4. Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen.
Mullins M; Froelke BR; Rivera MR
Clin Toxicol (Phila); 2009 Feb; 47(2):112-5. PubMed ID: 18787997
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
7. Overdose with modified-release paracetamol results in delayed and prolonged absorption of paracetamol.
Graudins A; Chiew A; Chan B
Intern Med J; 2010 Jan; 40(1):72-6. PubMed ID: 20561368
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet.
Ibáñez Y; Rodríguez JM; Luján M; Grattan TJ; Martin AJ; Burnett I
Curr Med Res Opin; 2006 Oct; 22(10):1893-7. PubMed ID: 17022846
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies.
Wilson CG; Clarke CP; Starkey YY; Clarke GD
Drug Dev Ind Pharm; 2011 Jul; 37(7):747-53. PubMed ID: 21244275
[TBL] [Abstract][Full Text] [Related]
11. Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose.
Wananukul W; Klaikleun S; Sriapha C; Tongpoo A
J Med Assoc Thai; 2010 Oct; 93(10):1145-9. PubMed ID: 20973316
[TBL] [Abstract][Full Text] [Related]
12. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose.
Sivilotti ML; Green TJ; Langmann C; Yarema M; Juurlink D; Johnson D
Clin Toxicol (Phila); 2010 Oct; 48(8):793-9. PubMed ID: 20932103
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction of hepatotoxicity in paracetamol poisoning.
Wong A; Graudins A
Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic effects of diphenhydramine or oxycodone in simulated acetaminophen overdose.
Halcomb SE; Sivilotti ML; Goklaney A; Mullins ME
Acad Emerg Med; 2005 Feb; 12(2):169-72. PubMed ID: 15692141
[TBL] [Abstract][Full Text] [Related]
15. Study of paracetamol 1-g oral solution bioavailability.
Farre M; Roset PN; Abanades S; Menoyo E; Alvarez Y; Rovira M; Baena A
Methods Find Exp Clin Pharmacol; 2008; 30(1):37-41. PubMed ID: 18389096
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
Gude AB; Hoegberg LC; Angelo HR; Christensen HR
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose.
Wong A; Sivilotti MLA; Graudins A
Clin Toxicol (Phila); 2017 Jun; 55(5):346-351. PubMed ID: 28421844
[TBL] [Abstract][Full Text] [Related]
18. A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose.
Shen F; Coulter CV; Isbister GK; Duffull SB
Clin Toxicol (Phila); 2011 Aug; 49(7):643-7. PubMed ID: 21854081
[TBL] [Abstract][Full Text] [Related]
19. [The relative bioavailability of paracetamol in suppositories in comparison to tablets].
Blume H; Ali SL; Elze M; Krämer J; Scholz ME
Arzneimittelforschung; 1996 Oct; 46(10):975-80. PubMed ID: 8992964
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two new formulations of paracetamol, compared with three marketed formulations, in healthy volunteers.
Sevilla-Tirado FJ; González-Vallejo EB; Leary AC; Breedt HJ; Hyde VJ; Fernández-Hernando N
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):531-5. PubMed ID: 14571283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
